Evonik to Reject BASF’s Raised €11 Billion Takeover Bid

The signal here is less the rejection than the condition attached to it: Evonik appears willing to talk if the price moves, which frames this as a valuation dispute rather than a definitive defense. That distinction matters for how consolidation in European specialty chemicals is read, since a board holding out for a higher number invites a revised approach rather than ending the conversation. Whether BASF returns with an improved offer, or whether Evonik's stance hardens into a genuine refusal, is the open question to watch.